WATCH ON-DEMAND: Tracks 1-4keyboard_arrow_right.
搜索&过滤器
keyboard_arrow_right.
keyboard_arrow_left
Hide
WATCH ON-DEMAND: Tracks 1-4
keyboard_arrow_left搜索&过滤器
搜索
溪流
WATCH ON-DEMAND: Tracks 1-4
搜索
溪流
这些按需演示文稿将在您方便的时间内每天24小时查看30天
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
会议名称:超越肝脏和目标交付会议主席的寡核苷酸交付:
- Yogesh Sanghvi, PhD-President那Rasayan Inc.
- Brian Sproat,Phd-Managing Director那Chemconsilium GVC
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
会议名称:下面的寡核苷酸会议主席和发言者的监管指导的进展情况下:
- 雷切尔奥尔-GSK Fellow, Data Strategy and Design, Director for Functional Genomics那glaxosmithkline研发
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
SESSION NAME: Peptides Derived from Natural Products SESSION CHAIRS & SPEAKERS BELOW:
- 托马斯·沃尔赫尔,博士-Director, Peptide Discovery那诺华Pharma AG
一经请求
轨道4:肽化学,制造和控制
SESSION NAME: Innovations in Peptide Manufacturing SESSION CHAIRS & SPEAKERS BELOW:
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Targeted Delivery of Antisense Oligonucleotides Using G Protein Coupled Receptors
- 塔齐哈普拉克什,博士。-执行研究员那Ionis Pharmaceutical.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Regulatory Developments in Therapeutic Oligonucleotides: Why It’s Important to Discuss
- 雷切尔奥尔-GSK Fellow, Data Strategy and Design, Director for Functional Genomics那glaxosmithkline研发
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
自然衍生的肽作为研究GPCR信号的新工具
- Christian Gruber,PHD-研究小组领导和副教授那维也纳医科大学
一经请求
轨道4:肽化学,制造和控制
Manufacture of Long-chain Peptides in Highest Quality
- Christian Schwarz,博士-CEO那numaferm gmbh.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Stealth Labeling of Oligonucleotides for Unperturbed Imaging
- Anders Dahlén, Ph.D.-Associate Director, Oligo Chemistry Team那Astazeneca.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
EPFIA位置,ICH策略和寡核苷酸指南进展的机制
- 马特·帕克金-CMC战略产品开发总监那GSK
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
Target Fishing with Peptide Natural Products by Chemogenomics
- 多米尼克霍普纳,博士。-科学家那诺华生物医学研究机构
一经请求
轨道4:肽化学,制造和控制
欧洲药典法规对晚期制造商变化期间肽的影响
- 史蒂文麦克林雷-肽过程开发部门经理那Almac Group.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Synthetic Oligonucleotides Targeting RNA and DNA
- Osama Saher-博士生那Karolinksa Institutet.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
CMC Regulatory Challenges in the Development of Oligonucleotide Therapeutics
- Susanne Kindermann.-制药技术监管经理那F. Hoffmann-La Roche AG
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
CXCR拮抗剂EPI-X4的鉴定,优化和临床前开发
- Jan Münch, PhD-Director那Ulm University
一经请求
轨道4:肽化学,制造和控制
Advances in Downstream Technologies for Peptide Manufacturing
- Olivier Ludemann-Hombourger,PHD-全球导演创新与战略那PolyPeptide Group
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
液,扩大寡核苷酸的Drugs by Harnessing Nature’s Delivery System
- Tony De Fougerolles, PhD-CEO那EVOX Therapeutics有限公司
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
ASO Regulatory Engagement Experience
- Mia Kiistala-副主任监管事务那生物原
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
毒液衍生的筛选工具作为新型引线的来源
- 史蒂文装饰-Founder and Chief Scientific Officer那Venomtech有限公司
一经请求
轨道4:肽化学,制造和控制
通过树脂环化策略进行二硫化肽制造的过程开发:其应用和限制
- Yi Yang, PhD-Lead Scientist那Ferring Pharmaceuticals A / S.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
脂肪酸缀合改善了眼睛中RNA治疗剂的功能性递送
- 查尔斯艾德森,博士-Vice President of Chemistry & Drug Development那DTX Pharma.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
会议名称:管理CMC活动,用于复杂和新兴寡核苷酸治疗椅子和扬声器以下:
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
Constrained Natural Peptides from Venoms
- Michel de Waard,Phd-科学顾问那Smartox Biotechnology
一经请求
轨道4:肽化学,制造和控制
会议名称:肽和寡核苷酸的绿色化学和寡核苷酸会议椅子和扬声器以下:
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
CMC Strategies for Complex Oligonucleotides
- 托马斯罗普-所有者和校长那Thomas Rupp咨询UG
一经请求
轨道4:肽化学,制造和控制
Circular Economy and Green Solid-Phase Peptide Synthesis
- Fernando Albericio,Phd-Research Professor, School of Chemistry那Kwazulu-Natal大学
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Building the World's Leading Muscle Disease Company
- 罗姆亚克兰裔-首席科学官员那达因治疗剂
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
会议名称:下面的肽会议椅子和扬声器的生物分析和药代动力学:
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
早期CMC和寡核苷酸的调节策略
- Marc Lemaitre,Phd-顾问那ML咨询
WATCH ON-DEMAND: Tracks 1-402:40-03:1030.
分钟
Track 3: Peptide Discovery, Preclinical and Clinical
使用专用LC表面提高肽的恢复,再现性和光谱质量
- Jennifer Nguyen.-博士生那University of Copenhagen
一经请求
轨道4:肽化学,制造和控制
Oligonucleotide Green Chemistry: A Contradiction in Terms?
- 本安德鲁斯,博士-科学调查员那GlaxoSmithKline
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
克服寡核苷酸治疗剂的细胞内递送挑战
- 马修木,博士-神经科学教授那牛津大学
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
SESSION NAME: Analytical Strategies for Oligonucleotides SESSION CHAIRS & SPEAKERS BELOW:
- Nadim Akhtar, PhD-主要科学家表征和控制策略那Astazeneca.
- Jessica Stolee, PhD-Associate Director, Pharma and ASO Analytical Deve那生物原
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
Bioanalysis of Peptides: Current Method Approaches and Future Trends
- Patrick Brennecke,博士-Technical Director Bioanalytical Translational Science那凯雷翁
一经请求
轨道4:肽化学,制造和控制
绿色,瘦和清洁 - GC-LPP:Aspens绿色连续液相肽合成
- IVO Eggen,PHD-Section Lead Chemistry - Development & Technical Support那Aspen OSS B.V.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Analysis of Antisense Oligonucleotides Using Ultra-high-resolution Mass Spectrometry
- 京湖徐,博士-质谱中的高级科学家那Astazeneca.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
TFR靶向寡核苷酸的肝脏递送的VHH纳米级
- Guillaume Jacquot,博士-Translational Research Manager那Vect-Horus.
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
肽治疗肽药代动力学评价的非纯案例研究
- Bruce Morimoto,Phd-副总统药物发展那Cerecin
一经请求
轨道4:肽化学,制造和控制
SESSION NAME: Drug Product Development Strategies for Oligonucleotides and Peptides SESSION CHAIRS & SPEAKERS BELOW:
- Nadim Akhtar, PhD-主要科学家表征和控制策略那Astazeneca.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Analytical Challenges and Opportunities for Development of Oligonucleotide Therapeutics
- Barbara Adamczyk, PhD-Senior Analytical Scientist, Advanced Drug Deliver那Astazeneca.
一经请求
轨道4:肽化学,制造和控制
计划第一次寡核苷酸药品活动时,“要考虑的点”
- Stefan Vonhoff,Phd-Vice President CMC那Noxxon Pharma AG
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
SiRNA纳米载体的干粉配方用于肺部给药
- Olivia Merkel-Professor, Department of Pharmacy那Ludwig-Maximilians-Universität München
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
Peptide Drug Development; Clinical Pharmacological Considerations
- 帕尔德·瓦哈斯特,博士-科学事务总监那凯雷翁
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
防读寡核苷酸的平台稳定性策略:第一部分 - ASO降解研究和预测稳定性建模
- 江威李,博士-Sr. Scientist, Analytical Development那生物原
一经请求
轨道4:肽化学,制造和控制
肽和寡核苷酸预填充注射器药品的商业规模和验证
- Umberto罗密欧-R&D Manager那Corden Pharma Caponago
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
会议名称:RNA治疗椅的药用化学椅子:
- Konrad Bleicher, PhD-专家科学家那F. Hoffmann-La Roche Ltd.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Advanced Backbone Chemistry for ASO Therapeutics
- Konrad Bleicher, PhD-专家科学家那F. Hoffmann-La Roche Ltd.
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
会议名称:Discovery和开发治疗和开发椅子和扬声器以下:
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
A Platform Stability Strategy for Anti-Sense Oligonucleotides: Part II - ASO program ICH Stability and Future Platform Strategy
- 菲利普百吉吉尔克里斯特-科学家II,全球稳定那生物原
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
肽合成中的一般反应简介及肽药物化学稳定性的预测
- Yi Yang, PhD-Lead Scientist那Ferring Pharmaceuticals A / S.
一经请求
轨道4:肽化学,制造和控制
Formulations and Process Development for Terminal Sterilization of Oligonucleotide Drug
- Nadim Akhtar, PhD-主要科学家表征和控制策略那Astazeneca.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Medicinal Chemistry of Antisense Oligonucleotide Drugs
- 塔齐哈普拉克什,博士。-执行研究员那Ionis Pharmaceutical.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
在低分辨率LC-MS仪器上使用源片段碎片进行序列敏感方法的标识测试策略和开发
- Tom Atherton, Ph.D.-高级科学家那GlaxoSmithKline
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
朝向乙型肝炎和D COR感染患者的治疗方法:进入抑制剂Myrcludex B的关键作用
- Stephan Urban, PhD-Professor, Department of Infectious Diseases, Tran那大学医院海德堡
一经请求
轨道4:肽化学,制造和控制
寡核苷酸药品的终端灭菌
- Angela Wagner, PhD-助理主要科学家,无菌和专业那Merck Sharpe&Dohme
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
骨干化学与立体化学对关键寡核苷酸性能的影响
- Chandra Vargeese,PHD-SVP, Head of Drug Discovery那WAVE Life Sciences
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
会议名称:肽和寡核苷酸的绿色化学和寡核苷酸会议椅子和扬声器以下:
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
Five Pre-clinical PoC studies and the Clinical Phase I Study of the Orally Available All-D-enantiomeric Peptide PRI-002 for the Treatment of Alzheimer’s Disease
- Dieter Willbold, Ph.D.-Director那Forschungszentrum Jülich
一经请求
轨道4:肽化学,制造和控制
会议名称:肽CMC策略会议椅子和扬声器以下:
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Circular Economy and Green Solid-Phase Peptide Synthesis
- Fernando Albericio,Phd-Research Professor, School of Chemistry那Kwazulu-Natal大学
一经请求
轨道4:肽化学,制造和控制
官能化钉子的分析测试和方法开发
- 托比亚斯哈拉克,博士-分析发展副主任那默克和CIE.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
通过化学改性改善了共轭SIRNA的特异性
- Mark Schlegel, PhD-Principal Scientist, RNAi Discovery那alnylam pharmaceuticals.
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
基于个人Neoantigen的癌症疫苗Neo-PV-01治疗转移性癌症
- Jesse Dong, PhD-副总统肽化学那Biontech.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Oligonucleotide Green Chemistry: A Contradiction in Terms?
- 本安德鲁斯,博士-科学调查员那GlaxoSmithKline
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
基于LNA的反义寡核苷酸的化学改性
- 杰斯珀尔维尔,博士-Professor, Center Director BioNEC那南丹麦大学
一经请求
Track 3: Peptide Discovery, Preclinical and Clinical
CEMET瞄准放射热处理的快速轨道开发:EMT-100后面的故事
- Christophe门户,博士-化学元首 - C-Met Portfolio项目领导者那Edinburgh Molecular Imaging Ltd
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
绿色,瘦和清洁 - GC-LPP:Aspens绿色连续液相肽合成
- IVO Eggen,PHD-Section Lead Chemistry - Development & Technical Support那Aspen OSS B.V.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
针对多药抗革兰阴性细菌的精确PNA-反义抗生素
- Peter Nielsen, PhD-Professor那University of Copenhagen
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
SESSION NAME: Drug Product Development Strategies for Oligonucleotides and Peptides SESSION CHAIRS & SPEAKERS BELOW:
- Nadim Akhtar, PhD-主要科学家表征和控制策略那Astazeneca.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
计划第一次寡核苷酸药品活动时,“要考虑的点”
- Stefan Vonhoff,Phd-Vice President CMC那Noxxon Pharma AG
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
会议名称:与化学修改的寡核苷酸和共轭会话椅有关的安全问题:
- 亚瑟莱文,博士-首席科学官员那亲密的生物科学
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
RNA治疗安全
- Patrik Andersson, PhD-RNA治疗安全Lead那Astazeneca.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
肽和寡核苷酸预填充注射器药品的商业规模和验证
- Umberto罗密欧-R&D Manager那Corden Pharma Caponago
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Nonclinical Safety Assessment for GalNac3-Conjugated TTR ASO and Inotersen
- Tae-Won Kim,Phd-Executive Director Toxicology那Ionis Pharmaceutical.
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
Formulations and Process Development for Terminal Sterilization of Oligonucleotide Drug
- Nadim Akhtar, PhD-主要科学家表征和控制策略那Astazeneca.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
会议名称:Discovery,临床前和临床开发寡核苷酸会议椅子和扬声器以下:
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
立体寡核苷酸Aupport高效RNA编辑内源性ADAR酶
- Chikdu Shivalila, PhD-高级科学家,生物学那波浪生命科学
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
寡核苷酸药品的终端灭菌
- Angela Wagner, PhD-助理主要科学家,无菌和专业那Merck Sharpe&Dohme
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
脱胸部治疗症的管道进展
- Marc Abrams,Phd-Vice President, Discovery Research那Dicerna Pharmaceuticals
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
会议名称:寡核苷酸CMC策略会议椅子和扬声器以下:
一经请求
Track 2: Oligonucleotide Chemistry, Manufacturing and Controls
QBD和DOE对寡核苷酸的方法 - 过程鲁棒性的应用
- Thomas Emery-Associate Scientist那GSK
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Delivery of Antisense Oligonucleotide-loaded Exosome to Target Macrophage Reprogramming, Reduce the Immunosuppressive Tumor Microenvironment and Generate Potent Anti-tumor Efficacy
- Wendy Broom, PhD-肿瘤主任那Codiak Biosciences.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
MiRNA Therapeutics: From Bench to Bedside
- Ekkehard Leberer,博士-研发联盟管理高级总监那萨诺菲
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
会议名称:寡核苷酸共轭策略会议主席:
- Jimmy Wetersings,PHD-Principal Scientist, Oligonucleotide Chemistry那Astazeneca.
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
Development of a Toolbox for Optimizing Therapeutic siRNA Conjugates
- Marie Lindholm, PhD-Vice President, Molecular Design那Silence Therapeutics
一经请求
Track 1: Oligonucleotide Discovery, Preclinical and Clinical
The Art of Making Oligonucleotide Conjugates
- Jimmy Wetersings,PHD-Principal Scientist, Oligonucleotide Chemistry那Astazeneca.
获得最新消息。
As it happens
注册以获得最新议程和发言人。
Filter
溪流
Choose Day
- WATCH ON-DEMAND: Tracks 1-4WATCH ON-DEMAND: Tracks 1-4
- 观看按需:曲目5-7观看按需:曲目5-7
- WATCH ON-DEMAND: Spotlight PresentationsWATCH ON-DEMAND: Spotlight Presentations
- 目录Live Live 11月11日(CET)目录Live Live 11月11日(CET)
- WATCH LIVE Nov. 12 (CET)WATCH LIVE Nov. 12 (CET)
- 观看Live Live 11月13日(CET)观看Live Live 11月13日(CET)
- Download Agenda